"The Endocrine Center - Houston, TX At The Endocrine Center, we are a group of board-certified specialists in endocrinology and metabolism. We provide in-depth specialty care, and have a wide range of resources available for our patients. We accept a wide range of insurance plans, and can usually accommodate new patient appointments within 2 weeks. We have 3 locations in the Houston area: Main Campus, Greater Heights, Methodist West. We can usually accommodate new patient appointments within 2 weeks. Call on our board-certified specialists to help answer your questions regarding treatment and care: 713-468-2122."

During the past decade, The Endocrine Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Endocrine Center" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "CSL Behring" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Teijin America, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Endocrine Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Endocrine Center" are "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Kidney Disease" (1 trials), "Diabetic Kidney Disease (DKD)" (1 trials) and "Non-alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "The Endocrine Center" in a lesser frequency.

Most popular intervention types in "The Endocrine Center" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "CSL346" (1 trials), "Dulaglutide" (1 trials), "Insulin glargine" (1 trials) and "Insulin lispro" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Endocrine Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "The Endocrine Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Endocrine Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Endocrine Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".